Popular Articles

Today's Selection Of Opinions And Editorials
Lifting A Burden Of Worry The Washington Post

Australian Researchers Identify Genes That Cause Melanoma
Scientists from the Queensland Institute of Medical Research (QIMR) have found two new genes that together double a person"s risk of developing melanoma.
News of the day
U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults for the treatment of type 2 diabetes mellitus. ONGLYZA once daily can be used in combination with commonly prescribed oral anti-diabetic medications metformin, sulfonylureas or thiazolidinediones (TZD) or as a monotherapy to significantly reduce glycosylated hemoglobin (A1C) levels. ONGLYZA should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis (high levels of certain acids, known as ketones, in the blood or urine). ONGLYZA has not been studied in combination with insulin.
Cardiovascular

Warning On Untreated Bitter Lupins After Two Women Become Ill, Australia

Consumers should be warned about the dangers of eating untreated bitter lupin beans after two people who consumed products containing the beans became ill with anticholinergic syndrome, according to an article in the Medical Journal of Australia. Lupins are a legume or pulse, and commonly eaten species may be either sweet or bitter. Sweet lupin flour is increasingly being added to bread to reduce glyaecemic index and reduce energy intake, and to sausages to decrease fat intake. Bitter lupins can also be eaten, but need to be treated first to remove excessive and dangerous levels of toxic alkaloids. Two women presented separately to a West Australian metropolitan hospital in September 2007 when they became ill after eating products which contained bitter lupin flour purchased from the same chain of grocery stores. Symptoms included dry mouth, lethargy, difficulty mobilising, blurred vision and light-headedness. Subsequent investigations revealed that, when the supply of sweet lupin flour was exhausted, a quantity of bitter lupins had been milled into flour, which was distributed to a number of stores. The lupin beans contained 1000 times the alkaloid level of flour permitted under the Australia New Zealand Food Standards Code. Ms Nevada Pingault, an Epidemiologist at WA Health"s Communicable Disease Control Directorate, said failure to remove alkaloids from lupins could result in lupin toxicity, manifesting as anticholinergic syndrome. "Fortunately, neither of the two women who presented to hospital became seriously ill. But lupin poisoning can be fatal," Ms Pingault said. "In light of the increasing consumption of lupin products, we recommend that information be provided to food suppliers and consumers about the dangers of selling and eating products containing bitter lupins that have not been appropriately treated to remove toxic alkaloids. "Doctors should question patients who present with symptoms of anticholinergic syndrome about their recent food consumption, particularly consumption of products which contain lupin." The Medical Journal of Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):